Table 2.
Hypothesis test |
95% Wald’s confidence interval for odds |
||||||
---|---|---|---|---|---|---|---|
Specific disorder of the legs | Comparison | Wald’s Chi-square | df | Significance | Odds | Lower | Upper |
Malleolar flare | 3 vs. 1 | 5.15 | 1.00 | 0.02 | 1.68 | 1.07 | 2.63 |
3 vs. 2 | 0.51 | 1.00 | 0.48 | 1.17 | 0.76 | 1.80 | |
Telangiectasis | 3 vs. 1 | 0.33 | 1.00 | 0.57 | 1.11 | 0.78 | 1.59 |
3 vs. 2 | 0.44 | 1.00 | 0.51 | 1.13 | 0.78 | 1.64 | |
Reticular veins | 3 vs. 1 | 1.98 | 1.00 | 0.16 | 1.30 | 0.90 | 1.87 |
3 vs. 2 | 0.00 | 1.00 | 0.98 | 1.01 | 0.69 | 1.46 | |
Varicose veins | 3 vs. 1 | 7.51 | 1.00 | 0.01 | 1.69 | 1.16 | 2.46 |
3 vs. 2 | 9.09 | 1.00 | < 0.001 | 1.82 | 1.23 | 2.68 | |
Edema | 3 vs. 1 | 20.56 | 1.00 | < 0.001 | 2.37 | 1.63 | 3.44 |
3 vs. 2 | 30.04 | 1.00 | < 0.001 | 2.94 | 2.00 | 4.33 | |
Pigmentation | 3 vs. 1 | 57.01 | 1.00 | < 0.001 | 7.35 | 4.38 | 12.34 |
3 vs. 2 | 35.06 | 1.00 | < 0.001 | 4.21 | 2.62 | 6.78 | |
Eczema | 3 vs. 1 | 16.94 | 1.00 | < 0.001 | 5.77 | 2.51 | 13.30 |
3 vs. 2 | 6.74 | 1.00 | < 0.001 | 2.44 | 1.25 | 4.79 | |
Lipodermatosclerosis | 3 vs. 1 | 20.97 | 1.00 | < 0.001 | 29.11 | 6.88 | 123.23 |
3 vs. 2 | 18.40 | 1.00 | < 0.001 | 6.82 | 2.84 | 16.40 | |
Scars from healed ulcers | 3 vs. 1 | 24.77 | 1.00 | < 0.001 | 36.86 | 8.90 | 152.57 |
3 vs. 2 | 26.80 | 1.00 | < 0.001 | 7.39 | 3.46 | 15.75 | |
Active ulcers | 3 vs. 1 | 12.10 | 1.00 | < 0.001 | 34.64 | 4.70 | 255.16 |
3 vs. 2 | 13.26 | 1.00 | < 0.001 | 9.14 | 2.78 | 30.06 |
Logistic regression was performed on each leg disorder separately while controlling for age and comorbidities. The predictor, site of injection/noninjection drug use group, was coded with Category 3 as the reference category. Because the odds ratio is symmetric, reversing the reference category of the outcome resulted in the contrasts indicated.